Anticancer Activity Evaluation of New Thieno[2,3-D]pyrimidin-4(3h)-Ones and Thieno[3,2-D]pyrimidin-4(3h)-One Derivatives
Scientia Pharmaceutica - Austria
doi 10.3390/scipharm86030028
Full Text
Open PDFAbstract
Available in full text
Categories
Date
July 16, 2018
Authors
Publisher
MDPI AG